1. Home
  2. FIZZ vs TVTX Comparison

FIZZ vs TVTX Comparison

Compare FIZZ & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Beverage Corp.

FIZZ

National Beverage Corp.

HOLD

Current Price

$34.15

Market Cap

3.2B

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$42.53

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIZZ
TVTX
Founded
1985
N/A
Country
United States
United States
Employees
N/A
497
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.8B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
FIZZ
TVTX
Price
$34.15
$42.53
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
1
13
Target Price
$35.00
$40.62
AVG Volume (30 Days)
167.2K
2.3M
Earning Date
03-12-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
5.29
92.89
EPS
1.53
N/A
Revenue
$1,201,354,000.00
N/A
Revenue This Year
$0.14
$44.76
Revenue Next Year
$3.33
$35.51
P/E Ratio
$22.05
N/A
Revenue Growth
0.81
N/A
52 Week Low
$31.21
$13.88
52 Week High
$47.88
$43.31

Technical Indicators

Market Signals
Indicator
FIZZ
TVTX
Relative Strength Index (RSI) 50.23 67.69
Support Level $32.58 $32.62
Resistance Level $35.86 N/A
Average True Range (ATR) 0.73 1.97
MACD 0.07 0.15
Stochastic Oscillator 54.05 92.10

Price Performance

Historical Comparison
FIZZ
TVTX

About FIZZ National Beverage Corp.

National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: